Tivara

Name: Tivara
Brand: Tivara

AI Native

Using LLMs to make healthcare more efficient

Est 2024|Valuation $7.1M|Raised $4.1M|2 Ref Customers

LinkedIn 972|Website|FTEs 5|HQ New York, NY

MarketsInteractive Voice Response (IVR)

Published Oct 8, 2026

01Common complaints

- Company sizes or stages where this product is overkill or insufficient - Solo or very small practices may find enterprise, quote-based voice automation uneconomical relative to call volume. - Industries or use cases where competitors are clearly superior - Large health systems requiring a mature multi-channel digital front door and extensive published controls/benchmarks may prefer more established enterprise platforms. - If prior authorization automation (submission, policy matching, tracking, appeals) is the primary need, specialized PA vendors may be more appropriate. - Technical requirements that this product may not meet - If an organization's EHR/PM cannot support reliable read/write integration (or access cannot be granted), the solution may degrade to message capture and not deliver full automation value. - Budget constraints that make alternatives more appropriate - Organizations requiring transparent, self-serve pricing and low minimums may find this vendor's quote-based model incompatible with budgeting constraints. - Specific workflows or integrations where the product may fall short - Workflows requiring highly nuanced clinical triage, complex multi-department scheduling, or real-time eligibility/benefits checks should be validated via pilot engagements; if these cannot be executed reliably, alternatives or hybrid approaches should be considered. - Red flags in the buying process - Lack of access to SOC 2 Type II report under NDA. - No clarity on data retention, subprocessors, and AI provider terms. - Inability to provide a realistic pilot plan with clear success metrics (containment rate, booking conversion, patient satisfaction). - Current limitations acknowledged by the vendor - The vendor acknowledges that out-of-scope or low-confidence calls require escalation to human staff. - Features on the roadmap (not yet available) - No public roadmap with dated commitments was found. - Scale limitations (at what volume/size does it break down?) - Not publicly documented. - Security or compliance gaps - The vendor reports HIPAA and SOC 2 Type II claims; however, detailed artifacts (SOC 2 report scope, subprocessors, penetration test summaries) are not publicly posted. - ISO 27001 is not publicly documented. - Technical debt or architectural limitations mentioned in reviews - No Tivara-specific review corpus was identified to assess technical debt. - API limitations or integration constraints - The vendor reports API and HL7 integration methods; specific endpoints, supported vendors, and limitations are not publicly enumerated and should be validated during the procurement process.

Deal disqualifiers: what makes a POOR fit

Very small practices with low call volume where enterprise voice automation is not cost-effective.
Organizations with highly customized scheduling rules that are difficult to encode and validate.
Patient populations or settings where voice-based automated interactions are likely to harm patient experience.

Why some customers left for competitors (churn reasons)

No Tivara-specific churn narratives were identified in accessible sources.
Category-level churn reasons commonly include:
- Patient dissatisfaction with AI phone agents.
- Workflow failures when conversations go off-script.
- Insufficient EHR/telephony integration preventing end-to-end automation.

02Why they buy

- Competitive advantages validated by customer feedback (not just vendor claims) - There is insufficient independent review volume to validate unique selling points via customer feedback. - Unique features and capabilities competitors lack - Tivara's stated capability set includes end-to-end automation of multiple phone workflows with EHR/PM writeback and escalation for low-confidence calls. - However, similar capabilities are claimed by other voice-agent vendors; differentiation depends on integration depth and specialty-specific workflow accuracy. - Differentiation from competitors based on reviews - There is not enough Tivara-specific review volume to substantiate differentiation claims. - Value propositions with evidence from case studies - The vendor does not publish quantified case studies publicly. - Areas where competitors clearly have advantages (be balanced) - Some competitors publish operational metrics and responsible AI controls that may reduce perceived risk for enterprise buyers.

Why customers chose this product over alternatives (inferred)

Based on Tivara positioning, likely reasons include:
- Need for 24/7 call coverage and reduction of abandoned calls.
- Requirement to book directly into EHR/PM systems rather than using external calendars.
- Focus on administrative workflow automation rather than clinical decision-making.

03Field reports

- Detailed customer success stories with metrics - Tivara's public site does not provide detailed case studies with quantified metrics. - Specific results and quantified business impact - Not publicly disclosed for Tivara. - Implementation details and time to value - The vendor reports a typical go-live in a short timeframe measured in weeks; this is a vendor-published claim. - Challenges faced during adoption and how they were resolved - Not publicly documented for Tivara. - CRITICAL: Note when metrics are vendor-published without independent verification - Tivara's public claims are largely qualitative; where claims exist (e.g., security/compliance assertions and reported deployment timelines), they are vendor-published and require independent verification.

Important availability note (review-source coverage)

Tivara is early-stage and is not widely represented on mainstream B2B review platforms (G2, TrustRadius, Capterra) based on accessible searches.
Gartner Peer Insights listing and other third-party review platforms did not surface Tivara product reviews in accessible results.

Direct quotes from Gartner Peer Insights, Reddit, TrustRadius, G2, HackerNews

- Gartner Peer Insights - No Tivara-specific reviews were located in accessible results. - G2 / TrustRadius - No Tivara product profile with reviews was located in public directories. - Reddit / HackerNews - No Tivara-specific threads were identified in accessible searches; available community discussions were category-level conversations about AI phone agents in healthcare rather than Tivara-specific experiences.

Vendor-published / press-reported testimonials (not equivalent to independent reviews)

Tivara's public site contains outcome-oriented claims (for example, improved access and reduced wait times) but lacks independently verified customer quotes on public pages.
Press reporting referenced customer adoption among specialty medical groups and named a small set of customers; these are press reports rather than user-generated reviews.

Common criticisms and complaints (from available community sources in this category)

- Tivara-specific independent reviews are scarce; therefore the strongest available signals are category-level critiques of healthcare voice agents: - Patient acceptance risk - In community discussions, clinics have reported reductions in new patient appointments after adopting voice agents and reverting the change after a brief trial due to negative patient feedback. - Reliability and off-script breakdowns - Community contributors emphasize that integration and workflow correctness are harder than the voice component itself; failures when patients deviate from expected dialogs are a common concern. - Integration depth as a deal-breaker - Users note that EHR scheduling/refill integration depth determines whether an agent can complete tasks end-to-end versus simply capturing messages.

Specific outcomes customers achieved (with metrics when available)

Tivara public materials do not include quantified case studies on the public site.
Competitors in the category publish metrics (for example, reductions in abandonment/wait times), but these results should not be attributed to Tivara without confirmation.

Deal-breakers and reasons customers didn't purchase

Likely deal-breakers based on category buying patterns:
- Inability to integrate with a target EHR/PM.
- Lack of clear proof of performance or ROI for a given specialty.
- Security review gaps (scope questions on SOC 2, lack of documented subprocessors).
- Patient dissatisfaction and brand risk.

04Best fit

Company sizes

Based on press reporting, Tivara targets small-to-midsize specialty medical groups with multiple providers.
Typical fit
- Multi-site specialty groups with sufficient call volume to justify automation.

Industries and verticals where adoption is strongest

Specialty clinics (oncology, orthopedics, dermatology, cardiology, gastroenterology, etc.) with high-volume scheduling and intake calls.

Roles and personas: decision makers AND end users

Decision makers
- COO, Head of Operations, Patient Access Director, Revenue Cycle Management leader, Practice Administrator, CIO/IT.
End users
- Call center/front desk staff, scheduling teams, nurses/on-call providers responsible for triage escalations.

Pain points and challenges the product addresses

High call abandonment and long hold times.
Staffing shortages and burnout in patient access roles.
Repetitive administrative tasks (refills, order requests, intake).
After-hours coverage gaps.

Qualification criteria: what makes a GOOD fit

High inbound call volume and measurable lost revenue from missed calls.
Willingness to standardize workflows and define escalation rules.
Accessible EHR/PM systems for integration (APIs/HL7).
Operational model that retains human-in-the-loop clinical judgment for exceptions.

Real customer examples with company names when available

Press reporting named Los Angeles Cancer Network and Astera Customer Care as customers; these mentions were not accompanied by independent case-study metrics.

05The pitch

What the product does (core value proposition in objective terms)

- Tivara is an AI agent platform for medical groups that automates high-volume patient phone workflows end-to-end—particularly scheduling, refills/order requests, intake, reminders, and after-hours triage—by integrating with EHR/EMR and practice management (PM/PMS) systems and writing outcomes back into those systems. - Tivara's earlier positioning (YC Launch) emphasized automating prior authorization submissions and approvals using large language models; recent messaging emphasizes patient engagement and voice automation across multiple call types.

Target market and market positioning

- Target buyers - Specialty medical groups and multi-provider clinics seeking to reduce call center/front desk volume and improve patient access. - Operations, patient access leaders, practice administrators, revenue cycle management leaders, and IT for integrations. - Market positioning - Positioned in the patient access segment as a provider of voice-based automation with workflow and EHR/PM integration. - Competes in the AI receptionist / AI scheduling agent category and, depending on module configuration, adjacent prior authorization automation.

Get a comprehensive analysis of Tivara including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →